Hints and tips:
Related Special Reports
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...Some pharma companies disputed the annual cost figures published by the health department....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...Legal hammer Oil supermajor ExxonMobil’s case against two climate activist groups has grabbed the attention of corporate America, the FT reports....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...Mizuho, Mitsubishi UFJ Financial Group and Sumitomo Mitsui Financial Group are among the pilgrims....
...In Amgen’s case, the FTC argued that the Big Pharma group could get buyers to favour Horizon’s drugs by bundling them with its own best medicines....
...Its headcount in the Americas has doubled since 2010 to just over 3,000....
...UBSO: 6; L: 7; I: 7; Total: 20The legal team at the bank advised on the sale of UBS and Mitsubishi’s joint venture, Mitsubishi Corp-UBS Realty, to global investment fund KKR for $2bn....
...“Humira is the most valuable biologic drug ever and AbbVie is known as one of the most aggressive pharma companies ever....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...Rivian founder and chief executive RJ Scaringe chose Normal for its first factory, buying a former Mitsubishi car plant weeks away from demolition for $16mn in 2017....
...Her public protests against members of the Sackler family, whose company Purdue Pharma produced the addictive OxyContin drug, are the backbone of the acclaimed film All the Beauty and the Bloodshed (2022...
...Instead of warning investors about risky investment in America’s most valuable company, the SEC warns investors about weak disclosures by Chinese companies....
...Iain Simpson, analyst at Barclays, said that following the ruling “we regard Zantac as substantially derisked, leaving Haleon investible again for those without the appetite for pharma litigation risk”....
...“People were thinking that I’m trying to go into the pharma business [as] window dressing for my tobacco business,” he says. He is accustomed to receiving a frosty reception from scientists....
...Medicago is majority owned by Mitsubishi Tanabe Pharma....
...Toshifumi Tada, head of vaccine business development at Mitsubishi Tanabe Pharma, said its subsidiary Medicago would apply for Canadian approval for its vaccine candidate that is made from a plant from the...
...The Tesla and SpaceX chief financed his $44bn deal to take Twitter private in October by securing the huge debt from a syndicate of banks led by Morgan Stanley, Bank of America, Barclays and Mitsubishi....
...Disappointing results might also act as a catalyst for a shift in funding for Alzheimer’s research, with some scientists arguing that promising areas of study and potential treatments have been crowded out by Big Pharma...
...It also sold $2.3bn of shares in the second quarter, cutting its stakes in General Motors, US Bancorp and grocer Kroger, and exited its positions in Verizon and Royalty Pharma....
...In comparison, sales at the pharma division grew 8 per cent to $45bn last year....
...Medicago, a unit of Mitsubishi Tanabe Pharma that is backed by Philip Morris International, is planning to launch the world’s first plant-based Covid-19 vaccine that is potentially cheaper and easier to...
...than pharma chiefs, typically $30mn or more each year, but the difference had narrowed....
International Edition